The antigen-specific serological response to Chlamydia pneumoniae was studied in 45 adults with coronary artery atherosclerosis and compared with that in 40 adults with acute respiratory infection. C. pneumoniae antigen and DNA were detected in lesions more frequently in patients with low immunoglobulin G titers against C. pneumoniae than in those with high immunoglobulin G titers. Reactivities with the 42-kDa (46%) and 52-kDa (31%) proteins were observed more frequently in sera from seropositive individuals with atherosclerosis than in sera from patients with acute respiratory infection. Antibodies against the C. pneumoniae-specific 42-and/or 52-kDa protein may be a marker for chronic C. pneumoniae infection.
Chiamydia pneumoniae is a recently characterized species of the genus Chlamydia. C. pneumoniae is a widespread respiratory pathogen. Seroepidemiological studies showed that >50% of the adult population worldwide have immunoglobulin G (IgG) antibody against the organism (2) . While C. pneumoniae has been established as an etiological agent of acute respiratory infections, serological evidence has also implicated an association of C. pneumoniae with other diseases, e.g., coronary heart disease, myocardial infarction (8, 11, 12) , and sarcoidosis (3) . A prospective study from Finland has indicated that chronic C. pneumoniae infection is a significant risk factor for coronary heart disease (9) . In that study, elevated microimmunofluorescence (micro-IF) antibody titers and the presence of circulating immune complexes containing the chlamydial lipopolysaccharide were used as indicators of chronic or past C. pneumoniae infection. Subsequently, C. pneumoniae has been demonstrated by electron microscopy, immunoperoxidase staining, and polymerase chain reaction in atherosclerotic lesions in the coronary arteries of autopsy patients from South Africa (4, 10) . This study was undertaken to analyze the serological response against C. pneumoniae in these individuals by the micro-IF test and immunoblot and to determine any antigenspecific reactivities which might serve as indicators of C. pneumoniae-associated atherosclerosis.
Postmortem sera from 45 South African adults with coronary arterial fatty streaks (n = 15) or fibrolipid plaques (n = 30) were studied. The majority of deaths were due to accident, homicide, and trauma. Only one died of coronary heart disease. Eighty-eight percent were male, and 61% were Caucasian, with the remaining being black and Asian Indian. Forty percent were 35 years old or younger. C. pneumoniaespecific DNA and/or antigen was detected in atherosclerotic lesions of coronary arteries in 22 of these adults (4 addition, sera from patients (n = 10) with acute C. pneumoniae respiratory infection proven by isolation and/or serology (a seroconversion, a fourfold rise or drop in antibody titers, IgG titer of >512, or IgM titer of >16) and sera from patients (n = 30) with acute respiratory infection who were antibody negative or who had low IgG antibody titers (8 to 16) against C. pneumoniae were analyzed. The patients were University of Washington students. C. pneumoniae antibodies in these patients were determined by the micro-IF test (14) . Statistical analysis was done by using Fisher's exact test.
The antigen-specific reactivity of sera was analyzed by immunoblotting as described earlier (1) . Briefly, lysates of purified elementary bodies of C. pneumoniae (AR-39), Chlamydia trachomatis (L2/434/Bu), and Chlamydia psittaci (6BC) and lysates of HeLa 229 cells (in which these organisms were grown) were electrophoresed in sodium dodecyl sulfate-13% polyacrylamide gel electrophoresis with a discontinuous buffer system (5) . After electrophoresis, separated proteins were transferred to nitrocellulose (13) . Subsequently, the filters were incubated in 3% bovine serum albumin (BSA) in Tris-buffered saline (TBS) for 1 h and in human sera diluted 1:20 in 1% BSA-TBS overnight. After being washed six times for 5 min each time in TBS-0.05% Tween 20, the nitrocellulose strips were incubated in horseradish peroxidase-conjugated anti-human immunoglobulin diluted 1:500 (Sigma Chemical Co., St. Louis, Mo.) for 1 h at 20°C. The nitrocellulose strips were washed with TBS-0.05% Tween 20 six times for 5 min each time and in TBS two times for 5 min each time. Color was developed by the addition of a-chloronaphthol (6 mg in 10 ml of TBS with 20% methanol) and 10 pl of H202. The positions of low-molecular-weight markers (Pharmacia, Piscataway, N.J.) and the efficiency of the transfer were checked by staining with Ponceau S solution (0.5% Ponceau S in 1% glacial acetic acid).
A high prevalence (87%) individuals with more-advanced lesions (GMT, 41.4 ± 5.0; n = 30) (P < 0.001). C pneumoniae was also detected in arterial lesions in individuals who were seronegative (Fig. 1) . Five of the six seronegative individuals were C. pneumoniae positive (4). Micro-IF IgG titers in cases with C. pneumoniae in the atherosclerotic lesion tended to be lower (GMT, 13.6 -4.2; n = 22) than in those with no C. pneumoniae in the atherosclerotic lesion (GMT, 53.4 -4.3; n = 23) (P < 0.001).
The significance of this observation is unknown. One possible explanation is that antibodies in these individuals were bound in immune complexes, as suggested by Saikku and colleagues (9) , and thus were not detectable in the micro-IF test. Alternatively, IgG antibodies may be protective and high IgG titers could assist in eradicating or suppressing the infection.
In immunoblots, the 42-and 52-kDa proteins were more often reactive with sera from subjects with atherosclerosis than with sera from patients with respiratory infection (P < 0.05 for the 52-kDa protein and P > 0.05 for the 42-kDa protein). Other proteins often recognized by sera from patients with acute C. pneumoniae infection (98, 75, 68, 60, and 30 kDa) (1) were also recognized, but at a lower frequency (P < 0.05 for the 60-kDa protein, P < 0.01 for the 75-kDa protein, P < 0.001 for the 68-and 30-kDa protein, and P > 0.05 for the 98-kDa protein) ( Table 1 ). The immunoblot profiles were similar between atherosclerosis groups who were positive and negative for C. pneumoniae except for reactivity against the 68-kDa protein. This protein was recognized only by sera from individuals in whom C. pneumoniae was not found in arterial lesions (P < 0.05). The immunoblot profile of the five serum specimens from individuals with atherosclerosis who had acute antibody showed a pattern similar to that of the sera from the college students who had acute respiratory infection. The 75-and 60-kDa proteins were recognized frequently by these sera.
Overall, the recognition of the C. pneumoniae major outer membrane protein in atherosclerosis sera was rare (18% of all seropositive atherosclerosis cases), and the reaction was genus specific because the sera also reacted with C. trachomatis and C. psittaci major outer membrane proteins. Likewise, recognition of 60-and 75-kDa proteins was crossreactive, as several of the sera reacted with proteins with similar molecular masses from the three species tested. Reactivity with the 42-, 52-, and 98-kDa proteins, and occasionally a 60-kDa protein, was C. pneumoniae specific. An example of an immunoblot with sera from patients with atherosclerosis and acute respiratory infection is shown in Fig. 2 . Of the control sera tested, micro-IF-negative sera showed no reactivity in immunoblotting, and sera with low IgG titers occasionally reacted weakly with 98-, 68-, or 60-kDa protein. None of the sera reacted with HeLa cell proteins. Sera from individuals with advanced atherosclerotic changes reacted most frequently with the 42-, 60-, and 52-kDa proteins of C. pneumoniae. Interestingly, these three proteins were also recognized most frequently by sera from patients with sarcoidosis (70, 65, and 50%, respectively) (7). Association of sarcoidosis with chronic C. pneumoniae infection has been reported elsewhere (3 antibodies dissociated from circulating immune complexes from patients with coronary heart disease have been identified to react specifically with the 42-and 98-kDa proteins of C. pneumoniae (6) . In acute C. pneumoniae respiratory infection, reactivity with the 60-kDa protein was often seen, while the 42-and 52-kDa proteins were seldom recognized (1, 7). These results suggest that reactivity with a C. pneumoniae 42-kDa and/or 52-kDa protein may be associated with chronic C. pneumoniae infection and might serve as a marker of chronicity.
